3Light RW. Pleural effusion. N Engl J Med 2002,346(25):1971～1977.
4Romero-Candeira S, Hernandez L, Romero-Brufao S et al. Is It Meaningful To Use BiochemicalParameters To Discriminate Between Transudative and Exudative Pleural Effusions? Chest.2002; 122:1524～ 1529.
5Aoe K,Hiraki A,Murakami T,et al. Diagnostic significance of Interferon-γ in tuberculous pleural effusions. Chest 2003, 123:740～744.
6Putnam, JB Jr. Malignant Pleural Effusions. Surgical Clinics of North America 2002;82(4) :867～883.
8Ferrer, J, Villarino, MA, Encabo, G, et al. Diagnostic utility of CYFRA21 - 1 ,carcinoembryonic antigen,CA 125, neuron specific enolase,and squamous cell antigen level determinations in the serum and pleural fluid of patients with pleural effusions. Cancer 1999,86,1488～ 1495.
9Antunes G,Neville E, Duffy J,et al. BTS guidelines for the management of malignant pleural effusion. Thorax, 2003; 58 (Suppl Ⅱ ) :ii29～ii38.
10Fer rer J,Villarion MA,Tura JM,et al. Talc preparations used for pleurodesis vary markedly from one preparation to another.Chest 2001; 119:1901～5.
二级参考文献7
1Dreyling M H，Cancer Res，1995年，55期，984页
2李静，中华结核和呼吸杂志，1994年，17期，183页
3钟南山，现代呼吸病进展，1994年，431页
4Light RW.Management of pleural effusions[].Thepleura in health and disease.1985
5Ogawa K,Koga H,Yang B. et al.Differential diagnosis of tuberculous pleurisy by the measurement of cytosine concentration in pleural effusion[].Kekkaku.1996
6Elg SA,Carson LF,Fowler JM,et al.Ascites levels of hapoglobin inpatients with overian cancer[].Cancer.1993
7Yehisey C,Fadiloglu M,Onvural B,et al.Clinical evaluation of copperand ceruloplasmin levels in effusions of malignant and benign origin[].Biochemical Society Transactions.1995
